C. Foussard

768 total citations
25 papers, 517 citations indexed

About

C. Foussard is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, C. Foussard has authored 25 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 9 papers in Genetics and 7 papers in Oncology. Recurrent topics in C. Foussard's work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Viral-associated cancers and disorders (6 papers). C. Foussard is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Viral-associated cancers and disorders (6 papers). C. Foussard collaborates with scholars based in France, Switzerland and Canada. C. Foussard's co-authors include Éric Deconinck, Vincent Delwail, Gilles Salles, Guillaume Cartron, Nöel Milpied, Hervé Maisonneuve, Rémy Gressin, Ambro van Hoof, Philippe Colombat and Beatrice Mahé and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

C. Foussard

24 papers receiving 506 citations

Peers

Countries citing papers authored by C. Foussard

Since Specialization

Citations

This map shows the geographic impact of C. Foussard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Foussard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Foussard more than expected).

Fields of papers citing papers by C. Foussard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Foussard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Foussard. The network helps show where C. Foussard may publish in the future.

Co-authorship network of co-authors of C. Foussard

This figure shows the co-authorship network connecting the top 25 collaborators of C. Foussard. A scholar is included among the top collaborators of C. Foussard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Foussard. C. Foussard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma 2013 ·Haematologica ·Emmanuel Bachy, Roch Houot, F. Morschhauser, Anne Sonet, Pauline Brice, Karim Belhadj, Guillaume Cartron, B. Audhuy, Christophe Fermé, Pierre Feugier, Catherine Sebban, Vincent Delwail, Hervé Maisonneuve, Steven Le Gouill, Sophie Lefort, Nicole Brousse, C. Foussard, Gilles Salles, (unknown)	60
2	Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up 2012 ·Annals of Oncology ·P Colombat, Nicole Brousse, Gilles Salles, Franck Morschhauser, Pauline Brice, Pierre Soubeyran, Vincent Delwail, Éric Deconinck, Corinne Haïoun, C. Foussard, Catherine Sebban, H. Tilly, Catherine Thiéblemont, Laurence Bergougnoux, (unknown), P. Solal-Céligny	36
3	Autologous transplantation in CLL patients with B and C Binet stages: final results of the prospective randomized GOELAMS LLC 98 trial 2011 ·Bone Marrow Transplantation ·A. Brion, Beatrice Mahé, Brigitte Kolb, B. Audhuy, P Colombat, Hervé Maisonneuve, C. Foussard, (unknown), (unknown), Jean‐François Lesesve, Massimiliano Del Bene, Pierre Feugier, (unknown)	19
4	Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study 2011 ·Haematologica ·Steven Le Gouill, Sophie de Guibert, Lucie Planche, (unknown), Jehan Dupuis, Guillaume Cartron, Ambro van Hoof, Olivier Casasnovas, Emmanuel Gyan, (unknown), (unknown), Éric Deconinck, Olivier Fitoussi, Lauris Gastaud, Vincent Delwail, Jean Gabarre, Rémy Gressin, Michel Blanc, C. Foussard, Gilles Salles, (unknown)	72
5	First-line rituximab (R) high-dose therapy (R-HDT) versus R-CHOP14 for young adults with diffuse large B-cell lymphoma: Preliminary results of the GOELAMS 075 prospective multicenter randomized trial. 2011 ·Journal of Clinical Oncology ·Steven Le Gouill, Nöel Milpied, (unknown), Vincent Delwail, Rémy Gressin, D Guyotat, Gandhi Damaj, C. Foussard, Guillaume Cartron, Hervé Maisonneuve, Éric Deconinck, F. Dreyfus, Emmanuel Gyan, Linda Sutton, Nadine Morineau, (unknown), (unknown), (unknown)	32
6	Lymphomes malins non hodgkiniens à petites cellules : facteurs pronostiques et traitements 2009 ·Médecine Nucléaire ·P Colombat, Séverine Lissandre, C. Foussard	1
7	Modes de révélation et présentation clinique des entités les plus fréquentes des lymphomes 2009 ·Médecine Nucléaire ·(unknown), (unknown), C. Foussard	1
8	Hypercalcémie et lymphome. À propos d'un cas 2007 ·La Revue de Médecine Interne ·(unknown), Christian Lavigne, N. Josselin, C. Foussard, (unknown), (unknown), Gilles Berrut	1
9	rHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot study 2005 ·Bone Marrow Transplantation ·Mathilde Hunault, Aline Schmidt, (unknown), Vincent Lévy, (unknown), Sylvie François, M Gardembas-Pain, M. Dib, C. Foussard, (unknown), Alban Godon, Philippe Solal‐Céligny, Norbert Ifrah	4
10	Long-term follow-up of a randomized trial of fludarabine–mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies 2005 ·Annals of Oncology ·C. Foussard, Philippe Colombat, Hervé Maisonneuve, Christian Berthou, Rémy Gressin, M.C. Rousselet, (unknown), B. Pignon, Beatrice Mahé, C Ghandour, B Desablens, Philippe Casassus, T. Lamy, Vincent Delwail, Éric Deconinck	14
11	Prospective Randomized Study Comparing MEMID with a Chop-Like Regimen in Elderly Patients with Aggressive Non-Hodgkin’s Lymphoma 2005 ·Oncology ·Emmanuel Chamorey, Rémy Gressin, Frédéric Peyrade, Jean François Rossi, G. Lepeu, C. Foussard, (unknown), Michel Fabbro, Bruno Richard, Vincent Delwail, Hervé Maisonneuve, Jean‐Pierre Vilque, Antoine Thyss	4
12	Efficacy and Safety of Oral Fludarabine Phosphate in Previously Untreated Patients With Chronic Lymphocytic Leukemia 2004 ·Journal of Clinical Oncology ·Jean François Rossi, Ambro van Hoof, K. De Boeck, S.A. Johnson, Dominique Bron, C. Foussard, Tim Lister, Christian Berthou, (unknown), Timothy J. Littlewood, Robert Marcus, Éric Deconinck, Marco Montillo, (unknown), Susan M. Tollerfield	36
13	Continuous Infusion of Vincristine-Doxorubicin with Bolus of Dexamethasone(VAD) Alternated with CHEP in the Treatment of Patients over 60 Years Old with Aggressive Non-Hodgkin's Lymphoma 2001 ·Leukemia & lymphoma ·Guillaume Cartron, Laurent Voillat, B Desablens, Christine Le Maignan, Nöel Milpied, C. Foussard, José Dugay, (unknown), A. De Muret, Philippe Colombat	2
14	Autologous stem cell transplantation for anaplastic large‐cell lymphomas: results of a prospective trial 2000 ·British Journal of Haematology ·Éric Deconinck, T. Lamy, C. Foussard, Fanny Gaillard, Vincent Delwail, Philippe Colombat, Philippe Casassus, (unknown), A. Brion, Nöel Milpied, (unknown)	41
15	Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage 111-IV patients 1997 ·Annals of Oncology ·C. Foussard, B Desablens, Luc Sensebé, Sylvie François, Nöel Milpied, Éric Deconinck, Vincent Delwail, José Dugay, T. Lamy, C Ghandour, A. Le Mevel, Hervé Maisonneuve, P. Casassus, Philippe Colombat	32
16	Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, France. 1997 ·PubMed ·C. Foussard, B Desablens, Luc Sensebé, Sylvie François, Nöel Milpied, Éric Deconinck, Vincent Delwail, José Dugay, (unknown), C Ghandour, A. Le Mevel, Hervé Maisonneuve, P. Casassus, Philippe Colombat	19
17	A randomized trial of hydroxyuea (HY) versus VP16 in advanced adult chronic myelomonocytic leukemia 1994 ·Leukemia Research ·Eric Wattel, A. Guerci, B Hecquet, T. Economopoulos, A. Copplestone, L Resegotti, (unknown), C. Foussard, Brigitte Pegourié, J. L. Michaux, Éric Deconinck, A. M. Stoppa, G J Mufti, D. Oscier, Pierre Fenaux	1
18	Rearrangements of the RARA and PML genes in a cytogenetic variant of acute promyelocytic leukemia 1993 ·Genes Chromosomes and Cancer ·Laurence Baranger, Martine Gardembas, Josette Hillion, C. Foussard, Norbert Ifrah, M Boasson, Roland Berger	7
19	[Influence of the autonomic nervous system on the normal and pathological atrioventricular node]. 1987 ·PubMed ·(unknown), C. Foussard, Jocelyn Laporte, (unknown), (unknown)	3
20	[Influence of intravenous clonidine on normal and pathological sinus and atrioventricular nodes and carotid sinus sensitivity]. 1985 ·PubMed ·(unknown), C. Foussard, Audrey Bouvier, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact